Metolazone



Indications and Reactions:

Role Indications Reactions
Primary
Fluid Retention 11.5%
Cardiac Failure Congestive 10.8%
Oedema 10.1%
Pulmonary Arterial Hypertension 9.4%
Diuretic Therapy 8.6%
Cardiac Failure Chronic 7.9%
Type 2 Diabetes Mellitus 7.2%
Hypertension 6.5%
Cardiac Failure 5.0%
Cardiac Disorder 2.9%
Renal Disorder 2.9%
Renal Failure Chronic 2.9%
Generalised Oedema 2.2%
Oedema Peripheral 2.2%
Rheumatoid Arthritis 2.2%
Thrombosis Prophylaxis 2.2%
Cardiovascular Disorder 1.4%
Chronic Obstructive Pulmonary Disease 1.4%
Polyuria 1.4%
Upper Respiratory Tract Infection 1.4%
Renal Failure Acute 20.6%
Vomiting 9.5%
Hypokalaemia 7.9%
Hypotension 7.9%
Renal Failure Chronic 6.3%
Renal Failure 4.8%
Weight Decreased 4.8%
Blood Potassium Decreased 3.2%
Disease Progression 3.2%
Muscle Spasms 3.2%
Nausea 3.2%
Pancreatitis 3.2%
Pancreatitis Acute 3.2%
Pulmonary Congestion 3.2%
Renal Impairment 3.2%
Syncope 3.2%
Torsade De Pointes 3.2%
Wrong Drug Administered 3.2%
Agranulocytosis 1.6%
Anaemia 1.6%
Secondary
Product Used For Unknown Indication 38.7%
Drug Use For Unknown Indication 12.8%
Hypertension 5.9%
Cardiac Failure Congestive 5.8%
Cardiac Failure 5.1%
Type 2 Diabetes Mellitus 3.7%
Cardiac Failure Chronic 3.5%
Pain 2.9%
Diabetes Mellitus 2.8%
Pulmonary Arterial Hypertension 2.8%
Angina Pectoris 2.3%
Sepsis 2.2%
Diuretic Therapy 2.0%
Depression 1.9%
Atrial Fibrillation 1.4%
Renal Failure Acute 1.3%
Chronic Obstructive Pulmonary Disease 1.2%
Oedema 1.2%
Prophylaxis 1.1%
Coronary Artery Disease 1.1%
Renal Failure Acute 20.3%
Toxicity To Various Agents 8.9%
Vomiting 7.6%
Hypokalaemia 7.0%
Death 6.3%
Tremor 5.1%
Confusional State 3.8%
Medication Error 3.8%
Poisoning 3.8%
Syncope 3.8%
Allergic Myocarditis 3.2%
Cardio-respiratory Arrest 3.2%
Nausea 3.2%
Respiratory Arrest 3.2%
Somnolence 3.2%
Torsade De Pointes 3.2%
Urticaria 3.2%
Azotaemia 2.5%
Dizziness 2.5%
Hypotension 2.5%
Concomitant
Product Used For Unknown Indication 35.7%
Drug Use For Unknown Indication 21.4%
Pulmonary Arterial Hypertension 6.0%
Hypertension 5.4%
Atrial Fibrillation 3.9%
Pain 3.4%
Diabetes Mellitus 2.9%
Cardiac Failure Congestive 2.2%
Type 2 Diabetes Mellitus 2.2%
Pulmonary Hypertension 2.1%
Cardiac Disorder 2.0%
Chronic Obstructive Pulmonary Disease 1.8%
Multiple Myeloma 1.6%
Blood Cholesterol Increased 1.5%
Depression 1.4%
Nuclear Magnetic Resonance Imaging 1.4%
Fluid Retention 1.3%
Gout 1.3%
Diuretic Therapy 1.3%
Prophylaxis 1.2%
Vomiting 13.9%
Weight Increased 10.9%
Death 10.4%
Weight Decreased 9.7%
Renal Failure Acute 5.7%
Renal Failure 5.0%
Ventricular Tachycardia 4.3%
Wheezing 4.2%
Thrombocytopenia 3.5%
Cardiac Failure Congestive 3.3%
Respiratory Failure 3.3%
Urinary Tract Infection 3.3%
Blood Glucose Increased 2.9%
Syncope 2.9%
Wound Infection 2.9%
Pneumonia 2.8%
Therapeutic Agent Toxicity 2.8%
Unevaluable Event 2.8%
Vision Blurred 2.6%
Pain 2.5%
Interacting
Product Used For Unknown Indication 45.0%
Drug Use For Unknown Indication 18.8%
Pain 15.0%
Essential Hypertension 12.5%
Atrial Fibrillation 3.8%
Cardiac Disorder 1.3%
Depression 1.3%
Nephrogenic Anaemia 1.3%
Renal Failure Chronic 1.3%
Confusional State 13.3%
Dehydration 13.3%
Delirium 6.7%
Diarrhoea 6.7%
Disorientation 6.7%
Drug Interaction 6.7%
Hypokalaemia 6.7%
Hyponatraemia 6.7%
Nasal Disorder 6.7%
Sinus Bradycardia 6.7%
Stupor 6.7%
Syncope 6.7%
Visual Impairment 6.7%